SCHEMBL2304848

SCHEMBL2304848

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](OS(=O)(=O)O)CC[C@@]4(C)[C@@H]3CC[C@]12C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP46A1 Q9Y6A2 3/20 1.00
NR1H3 Q13133 3/20 0.83
POLA1 P09884 1/20 0.74
OSBP P22059 3/20 0.71
USP2 O75604 2/20 0.71
RORC P51449 2/20 0.71
LMNA P02545 1/20 0.71
ABCB1 P08183 1/20 0.71
OSBP2 Q969R2 1/20 0.71
GRIN2A Q12879 2/20 0.63
GRIN2D O15399 1/20 0.63
GRIN2B Q13224 1/20 0.63
GRIN2C Q14957 1/20 0.63
GRIN1 Q05586 1/20 0.61
GBA1 P04062 2/20 0.60
UGCG Q16739 2/20 0.60
GBA2 Q9HCG7 2/20 0.60
NPC1L1 Q9UHC9 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL161397 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL3509637 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL192029 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL25063545 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL22077526 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL25063542 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL16248291 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL21334348 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL21824301 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2
SCHEMBL29094045 1.00 CYP46A1 (1.00) CYP46A1NR1H3POLA1OSBPUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0890577-B1 Composition comprising an aqueous dispersion of lipid vesicules, based on cholesteryl carbamates, cosmetic use and compounds OREAL (FR) 2002-11-06 EP claimed
EP-0775479-B1 Composition comprising an aqueous dispersion of lipid vesicles encapsulating an acid-functional UV-filter and its use in topical application OREAL (FR) 1998-10-28 EP claimed
EP-0544874-B1 METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS OREAL (FR) 1998-04-08 EP claimed
EP-0775479-A1 Composition comprising an aqueous dispersion of lipid vesicles encapsulating an acid-functional UV-filter and its use in topical application L'OREAL (FR) 1997-05-28 EP claimed
EP-0544874-A1 METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS L'OREAL (FR) 1993-06-09 EP claimed
WO-1993000068-A1 METHOD FOR PREPARING SUBMICRON PARTICLES IN THE PRESENCE OF LIPID VESICLES, AND CORRESPONDING COMPOSITIONS L'OREAL (FR) 1993-01-07 WO claimed
EP-0265467-B1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS L'OREAL (FR) 1990-07-04 EP claimed
EP-0265467-A1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS. OREAL (FR) 1988-05-04 EP claimed
WO-1987006499-A1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS L'OREAL (FR) 1987-11-05 WO claimed
EP-4727527-A2 GRP78 TARGETED LIPOSOMAL NANOPARTICLES (TLNPS) FOR THE TREATMENT OF CANCER University of Notre Dame du Lac (US) 2026-04-22 EP disclosed
EP-4619036-A1 PRODRUG STRATEGY THAT ENHANCES EFFICACY AND LOWERS SYSTEMIC TOXICITY OF MERTANSINE University of Notre Dame du Lac (US) 2025-09-24 EP disclosed
WO-2024259421-A2 GRP78 TARGETED LIPOSOMAL NANOPARTICLES (TLNPS) FOR THE TREATMENT OF CANCER UNIVERSITY OF NOTRE DAME DU LAC (US) 2024-12-19 WO disclosed
WO-2024108173-A1 PRODRUG STRATEGY THAT ENHANCES EFFICACY AND LOWERS SYSTEMIC TOXICITY OF MERTANSINE UNIVERSITY OF NOTRE DAME DU LAC (US) 2024-05-23 WO disclosed
WO-2023070071-A2 SMALL MOLECULE ACTIVATORS OF THE IMMUNE SYSTEM THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2023-04-27 WO disclosed
EP-0582503-A1 Composition formed of an aqueous dispersion of stabilized vesicles of amphiphilic non-ionic lipids L'OREAL (FR) 1994-02-09 EP disclosed
EP-0265467-B1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS L'OREAL (FR) 1990-07-04 EP disclosed
EP-0265467-B1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS L'OREAL (FR) 1990-07-04 EP disclosed
EP-0265467-A1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS. OREAL (FR) 1988-05-04 EP disclosed
WO-1987006499-A1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS L'OREAL (FR) 1987-11-05 WO disclosed
WO-1987006499-A1 METHOD FOR FACILITATING THE FORMATION OF LIPIDIC SPHERULES DISPERSED IN AN AQUEOUS PHASE AND FOR IMPROVING THEIR STABILITY AND THEIR ENCAPSULATION RATIO, AND CORRESPONDING DISPERSIONS L'OREAL (FR) 1987-11-05 WO disclosed